DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Raftopoulos H, Cooper W, O’Boyle E. et al.
Comparison of an extended-release formulation of granisetron (APF530) versus
palonosetron for the prevention of chemotherapy-induced nausea and vomiting
associated with moderately or highly emetogenic chemotherapy: Results of a
prospective, randomized, double-blind, non-inferiority phase 3 trial.
Support Care Cancer 2015;
23: 723-732
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.